Maternal Phenylketonuria and Offspring Outcome: A Retrospective Study with a Systematic Review of the Literature
Authors:
- Guido LeoneGLGuido Leone
- Concetta MeliCMConcetta Meli
- Raffaele FalsaperlaRFRaffaele Falsaperla
- Federica GulloFGFederica Gullo
- Laura LicciardelloLLLaura Licciardello
- Luisa La SpinaLSLuisa La Spina
- Marianna MessinaMMMarianna Messina
- Manuela Lo BiancoMBManuela Lo Bianco
- Annamaria SapuppoASAnnamaria Sapuppo
- Maria Grazia PappalardoMPMaria Grazia Pappalardo
- Riccardo IacobacciRIRiccardo Iacobacci
- Alessia ArenaAAAlessia Arena
Open Access
Abstract
Background: Phenylketonuria (PKU) poses significant challenges for maternal and neonatal outcomes, requiring strict adherence to dietary protocols to maintain optimal maternal phenylalanine (Phe) levels during pregnancy. This study retrospectively analyzed outcomes of pregnancies in PKU-affected women and conducted a systematic review on the timing of dietary management and its impact on outcomes. Methods: This retrospective study included data from nine PKU-affected women and 14 pregnancies followed at the Regional Reference Center for Metabolic Diseases in Catania. Women were categorized based on the timing of dietary intervention: preconception (pcD), during pregnancy (pD), or never (nD). Maternal Phe levels were classified as in-target (tP+) or non-target (tP−). A systematic review of the literature was conducted using PRISMA methodology, including 77 studies reporting maternal Phe levels, dietary timing, and clinical/auxological offspring outcomes. Results: In the retrospective study, pcD and tP+ groups had significantly better neonatal outcomes, with lower rates of congenital heart disease (CHD), facial dysmorphisms, intrauterine growth restriction (IUGR), and microcephaly. Systematic review data from 1068 PKU-affected women and 2094 pregnancies revealed that pcD with tP+ resulted in the lowest rates of miscarriage (0.14%) and adverse neonatal outcomes, while tP− and nD groups showed the highest rates of CHD, microcephaly, and intellectual disability. Conclusions: Early dietary intervention, ideally preconceptionally, and achieving target maternal Phe levels are critical in reducing adverse outcomes in pregnancies of PKU-affected women. These findings emphasize the importance of metabolic control and adherence to dietary protocols in maternal PKU management.Keywords
This publication has 88 references indexed in Scilit:
- The impact of phenylalanine levels during pregnancy on birth weight and later development in children born to women with phenylketonuriaJournal of Inherited Metabolic Disease, 2023
- Impact of pregnancy planning and preconceptual dietary training on metabolic control and offspring's outcome in phenylketonuriaJournal of Inherited Metabolic Disease, 2022
- Lobar holoprosencephaly in an infant born to a mother with classic phenylketonuriaAmerican Journal of Medical Genetics, 2000
- Maternal Phenylketonuria: An International StudyMolecular Genetics and Metabolism, 2000
- Outcome at Age 4 Years in Offspring of Women With Maternal PhenylketonuriaJAMA, 2000
- Mild Hyperphenylalaninemia and Heterozygosity of the Phenylalanine Hydroxylase GeneMolecular Genetics and Metabolism, 1998
- Maternal phenylketonuria collaborative study (MPKUCS) offspring: Facial anomalies, malformations, and early neurological sequelaeAmerican Journal of Medical Genetics, 1997
- Late diagnosis of phenylketonuria in a bedouin motherAmerican Journal of Medical Genetics, 1992
- Comparison of phenylketonuric and nonphenylketonuric sibs from untreated pregnancies in a mother with phenylketonuriaAmerican Journal of Medical Genetics, 1992
- Outcome of pregnancy in a phenylketonuric mother after low phenylalanine diet introduced from the ninth week of pregnancyEuropean Journal of Pediatrics, 1981